The CAR-TCR Summit Asia is the dedicated platform focused on ensuring the clinical translation of CAR-T and TCR therapies to the market globally, ensuring affordability and accessibility to all those in need.
Main topics this year include:
■ Solid Tumors: Develop the next generation CAR-TCR therapies directed at novel targets to treat solid tumor indications
■ Autologous vs Allogeneic: Identify the challenges and opportunities for cost effective and efficacious therapies
■ Manufacturing: Ensure streamlined scale up and out of engineered cell immunotherapies with innovative automation solutions
■ Regulations: Maneuver through the global regulatory landscape to ensure approval success
■ Commercialization: Explore the novel transport and logistics developments needed to ensure efficient delivery of CAR-TCR therapies globally
Download the event guide to view the full speaker faculty and event program.